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Trabecular meshwork cells play an important role in the 
regulation of aqueous outflow and open-angle glaucoma. 
Open angle glaucoma is known to occur with increased 
resistance of the outflow pathway due to the decreased cel-
lularity and altered ultrastructure of the trabecular mesh-
work [1,2]. Free radical nitric oxide (NO) plays important 
physiological roles [3-5] and is involved in the regulation of 
outflow through the trabecular meshwork as the activation 
of NO synthetase lessens in glaucoma [6-9]. Decreased NO 
leads to the production of other intermediate species and 
covalently modified biomolecules that cause injury and 
cellular dysfunction. Down-regulation of endothelial nitric 
oxide synthase and increased generation of oxygen-derived 
free radicals leads to early inactivation of NO, which in 
turn promotes further generation of oxidants, possibly by 
uncoupling NO synthase. This vicious cycle provides an 
integrative explanation for the interrelation between NO 
deficiencies and an excess of oxygen-derived free radicals. 
The resultant increased oxidative stress is known to pro-
mote cellular senescence [10-12]. 
Advanced glycation end products (AGE) are formed by 
the non-enzymatic reactions of sugar and protein when 
the glucose concentration is abnormally elevated. AGE 
permanently accumulates in the blood vessels and then 
induces abnormal vasodilatation by restricting the physi-
ological activation of NO in old age or in patients with 
diabetes mellitus [13,14]. Additionally, AGE are prevalent 
in ocular diseases such as cataracts or proliferative diabetic 
retinopathy [15,16]. Increased levels of AGE in the corneal 
endothelium of diabetes patients and in the aqueous humor 
in pseudoexfoliation glaucoma [17,18] suggests that AGE 
can accumulate in the trabecular meshwork and compro-
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Purpose: To investigate the effect of advanced glycation end products (AGE) on oxidative stress and cellular 
senescence in cultured human trabecular meshwork cells (HTMC).
Methods: Primarily cultured HTMC were exposed to 0, 10, 50, 100, 200 µg/mL of glycated bovine serum albu-
min (G-BSA) for 5 days. Also co-exposed were L-arginine, sepiapterin, and antioxidant N-acetylcysteine (NAC). 
Cellular survival and production of nitric oxide (NO), superoxide, and reactive oxygen species were assessed 
by 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide assay, Griess assay, cytochrome c assay, 
and dichlorofluorescin diacetate assay, respectively. Senescence-associated β-galactosidase staining was 
performed to quantify the degree of cellular senescence.
Results: G-BSA decreased cellular survival, NO production, and increased superoxide production significantly 
in a dose-dependent manner. The effects of G-BSA were abolished with co-exposure of L-arginine, sepiapter-
in, and NAC. G-BSA enhanced cellular senescence accompanied by increased production of reactive oxygen 
species. G-BSA-induced cellular senescence was suppressed by application of L-arginine, sepiapterin, and 
NAC.
Conclusions: AGE enhances cellular senescence of HTMC accompanied with increased oxidative stress. 
AGE-induced oxidative stress and cellular senescence could be delayed by application of anti-oxidants.
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mise its function. Davies et al. [19] reported that glucose 
levels in the aqueous humor of patients with diabetes were 
significantly higher (3.2 mM vs. 7.8 mM) compared with 
levels in persons without diabetes. Although diabetes and 
metabolic abnormalities are not known to be significant 
risk factors for glaucoma [20], the possibility of resultant 
oxidative stress causing cellular damage by AGE still ex-
ists since oxidative stress can occur as result of AGE accu-
mulation [21].
The trabecular meshwork not only works as the outflow 
pathway, but also actively participates in the regulation of 
outflow. Since NO synthetase is expressed in the trabecular 
meshwork [22,23] and glucocorticoid receptors are found 
in trabecular meshwork cells [24], AGE could act on the 
trabecular meshwork and decrease NO generation.
If the NO generation is decreased by AGE, then intra-
ocular pressure could be increased by inhibiting relaxation 
of the trabecular meshwork. In addition, if AGE generates 
oxidative stress and promotes the senescence of trabecular 
meshwork cells, then AGE may cause dysfunction of the 
trabecular meshwork. However, it is not yet known wheth-
er AGE has such an effect on human trabecular meshwork 
cells. Therefore, the effects of AGE on the generation of 
NO and oxidative stress, and on the senescence of trabecu-
lar meshwork cells were investigated in this study.
Materials and Methods
Cell culture
Tissues were extracted from the area surrounding the 
chamber angle of an eyeball obtained from the eye bank 
that had been extracted within six hours of death. The eye 
had not previously been afflicted with ocular disease nor 
had it undergone any type of surgery. The trabecular mesh-
work was stripped away from the anterior chamber angle 
and the explants were moved to a culture plate coated with 
poly-L-lysine (Sigma, St. Louis, MO, USA) and cultured 
in Dulbecco’s modified Eagle’s medium (DMEM; Gibco, 
Gaithersburg, MD, USA) containing antibiotics (Gibco) 
and 10% fetal bovine serum (Gibco) at 5% CO2. After con-
firming that the trabecular meshwork cells had grown out 
into the surroundings of the explanted tissues, the explants 
were removed and the culture was continued. When the 
cells were confluent, they were treated with trypsin and 
subcultured at a ratio of 1:3 with a medium containing 
10% fetal bovine serum. The procedures performed were 
consistent with the tenets of the Declaration of Helsinki.
Preparation of advanced glycation end products-bovine 
serum albumin: glycated bovine serum albumin
Fetal bovine serum (50 mg/mL) without endotoxin, 100 
mmol/mL glyceraldehyde and 1 mmol/L phenylmethylsul-
fonyl fluoride (Sigma) were dissolved in PBS solution. The 
mixtures were incubated under aseptic conditions for seven 
days after filtering. After dialyses with PBS solution, the 
electrolytes were removed by chromatography (Amersham 
PD-10 column chromatography; Amersham Pharmacia 
Biotech, Piscataway, NJ, USA). To determine the efficiency 
of glycation, browning of the glycated bovine serum albu-
min (G-BSA) preparation was determined by measuring 
the absorbance at 340 nm using a spectrophotometer. The 
absorbance of G-BSA increased with time, whereas the 
absorbance of control BSA (without glyceraldehydes) did 
not [25]. The concentration of G-BSA was measured with 
the Bradford assay and samples were stored in the deep 
freezer until use [26].
Drug treatment
After dividing the cells (1 × 10
5 cells/well of a 24-well 
culture plate, 0.6 × 10
5 cells/well of a 96-well culture plate), 
they were allowed to attach for 24 hours. The medium 
was removed and then replaced with DMEM medium in-
cluding 1% fetal bovine serum and a low concentration of 
glucose (5 mM) to prevent the antioxidant effect of serum 
protein. The cells were exposed to 0, 10, 50, 100, and 200 
µg/mL G-BSA for five days. A culture with 25 mM man-
nitol was simultaneously initiated to exclude the effects of 
osmotic pressure induced by AGE. The cells in the 24-well 
and 96-well plates were exposed to 100 µM L-arginine 
(Sigma) and 100 µM sepiapterin (Sigma), which are known 
to promote the NO generation. The cells were also ex-
posed to an anti-oxidant of 50 µM N-acetylcysteine (NAC, 
Sigma) to reveal the effects of AGE on the generation of 
reactive oxygen species.
MTT and Griess assays
The effect of AGE on cell survival was assessed by 3-[4, 
5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide 
(MTT, Sigma) assay [27], a colorimetric test frequently 
used as a screening tool to determine cell survival and tox-
icity, and NO generation was measured using the Griess 
assay [28]. For the MTT assay, the cultures were incubated 
for four hours after treatment with 100 µL of MTT per 
well, then washed with PBS solution and transferred to a 
96-well culture plate. Then, 0.5 mL of dimethylsulfoxide 
was added to each well to dissolve the MTT formazan 
crystals. The absorbance was measured at 570 nm with a 
spectrophotometer (FLUOstar OPTIMA; BMG Labtech, 
Offenburg, Germany). Cell survival was computed as a 
percentage by dividing the absorbance values of the ex-
perimental group by the absorbance values of the control 
group, which was not treated. The Griess assay was per-
formed to measure the quantity of nitrite, a reactant in NO 
generation. After mixing the medium containing cells with 125
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the same quantity of Griess reagent (Sigma), the absor-
bance was measured at 540 nm using a spectrophotometer. 
Serial dilutions of sodium nitrite (Sigma) were used to 
generate a standard curve.
Measurement of reactive oxygen species
The generation of superoxide was measured with a mi-
croplate reader using modified cytochrome c reduction 
[29,30]. The reactive solution was prepared by mixing 160 
µM cytochrome c (Sigma) and 100 U/mL superoxide dis-
mutase (Sigma), and cells were exposed to 100 µL of this 
solution for 20 minutes. The quantity of cytochrome c re-
duced at 540 nm was measured over the course of an hour. 
The quantity of superoxide was expressed as nmol/10
6cell/
h, reflecting the quantity of cytochrome c (in nmol) re-
duced by 10
6 cells per hour with a 2.1 × 10
4/M/cm net ex-
tinction coefficient.
The generation of reactive oxygen species was measured 
using the dichlorofluorescin diacetate assay [31]. On the 
fifth day after treatment of cells in a 96-well culture plate, 
the medium was removed and cells were subsequently 
washed with PBS solution. Cells were then treated with 5 
µM dichlorofluorescin diacetate (Sigma), after which they 
were incubated for 30 minutes at 37°C in PBS in the dark. 
The change in fluorescence of oxidized dichlorofluorescin 
was measured at excitation and emission wavelengths of 
488 nm and 527 nm, respectively, using a fluorescence 
analyzer (FLUOstar OPTIMA).
Assessment of apoptosis
To investigate whether AGE generates apoptosis, flow 
cytometry was performed by double staining of fluoresce-
in isothiocyanite-labeled Annexin V/propidium iodide (PI) 
with a commercial kit (TACS Annexin V-FITC apoptosis 
detection kit; R&D systems, Minneapolis, MN, USA) [32]. 
After trypsinization and washing, 5 µL Annexin V and 
1 µL PI were added to a 100 µL cell suspension and incu-
bated at room temperature for 15 minutes, and then a 400 
µL buffer solution was added and mixed. Next, flow cyto-
metric analysis was performed (Cytomics 500FC; Beck-
man Coulter, Miami, FL, USA) at fluorescence emission 
wavelengths less than 530 nm and greater than 575 nm. 
Assessment of cellular senescence
A commercial senescence-associated β–galactosidase kit 
(SA-β-gal, Sigma) was used to measure β–galactosidase 
activity, which is characteristic of senescent cells [33,34]. 
SA-β-gal is used to assess abnormal enzymatic activity ob-
served in aging. The culture was incubated for two hours 
after adding staining solution; β–galactosidase in senes-
cent cells stains blue. The proportion of senescent cells 
was computed as a percentage by dividing the number of 
senescent cells stained blue by the total number of cells. 
A round optical glass with a grid dividing the view into 
five square fields was attached to the eyepiece of an optical 
microscope and used to count the number of cells in each 
field over ten fields. The average numbers of stained and 
total cells were determined for these ten fields (×100).
Statistical analysis
All experiments were performed with cells between the 
third and fifth passages and repeated three times. An un-
paired t-test was used to compare the experimental group 
and control group with a significance level of 0.05. Data 
are expressed as means ± SEMs.
Results
Cell culture 
The trabecular meshwork cells started to grow out into 
the surroundings of the tissue explants as a monolayer af-
ter two or three weeks of primary culture. The presence of 
trabecular meshwork cells was confirmed by their charac-
teristic morphology and their characteristic growth pattern 
as satellite colonies grew distant from the tissue explants 
[35,36].
Effects of advanced glycation end products on survival 
and nitric oxide generation 
When trabecular meshwork cells were exposed to 100 
µg/mL G-BSA for five days, cell survival was significantly 
decreased to 98.5% compared with non-exposed controls 
(p < 0.05) (Fig. 1). The decreased survival rate induced 
by G-BSA exposure was abolished by L-arginine and se-
piapterin, which increase the generation of NO and NAC 
as antioxidants, respectively (p > 0.05) (Fig. 2). Mannitol 
appeared not to have a significant effect on cell survival 
and thus it was inferred that the effect of AGE was not due 
to a change in osmotic pressure (data not shown).
AGE significantly decreased the quantity of NO gener-
ated in the medium (p < 0.05) (Fig. 3). The decrease in 
NO generation was abolished by L-arginine, sepiapterin 
and antioxidants (p > 0.05) (Fig. 4). Thus, the decrease in 
the survival of trabecular meshwork cells caused by AGE 
could be caused by a decrease in NO or induced oxidative 
stress.
Effects of advanced glycation end products on the 
generation of reactive oxygen species
Treatment with 10 µg/mL AGE significantly increased 
the generation of superoxide in trabecular meshwork cells 126
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(p < 0.05) (Fig. 5). The increased generation of superoxide 
was abolished by L-arginine, sepiapterin and NAC (p < 
0.05) (Fig. 6). AGE increased the generation of reactive 
oxygen species (p < 0.05) (Fig. 7), and this increase in 
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Fig. 1. Effect of advanced glycation end products (AGE) on the 
survival of trabecular meshwork cells. Exposure to 100 µg/mL 
AGE significantly decreased cellular survival (
*p < 0.05). 
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Fig. 3. Effect of advanced glycation end products (AGE) on the 
production of nitric oxide in trabecular meshwork cells. AGE sig-
nificantly decreased nitric oxide production in a dose-dependent 
manner (
*p < 0.05).
Fig. 4. L-arginine, sepiapterin, and N-acetylcysteine (NAC) 
abolished advanced glycation end products (AGE)’s inhibitory 
effects on the production of nitric oxide in trabecular meshwork 
cells exposed to AGE concentrations of 50 µg/mL and 100 µg/mL 
compared to non-exposed controls (
*p < 0.05).
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Fig. 5. Effect of advanced glycation end products (AGE) on the 
production of superoxide in trabecular meshwork cells. AGE sig-
nificantly increased superoxide production in a dose-dependent 
manner (
*p < 0.05).
Fig. 6. L-arginine, sepiapterin, and N-acetylcysteine (NAC) 
significantly decreased advanced glycation end products (AGE)-
induced superoxide production compared to non-exposed tra-
becular meshwork cells (
*,**p < 0.05).
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Fig. 2. Effect of advanced glycation end products (AGE) on the 
survival of trabecular meshwork cells. The decreased cellular 
survival caused by AGE was abolished by exposure to L-argi-
nine, sepiapterin, and N-acetylcysteine (NAC).127
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reactive oxygen species was abolished by NAC (p < 0.05) 
but not by L-arginine or sepiapterin (p > 0.05) (Fig. 8).
Effect of advanced glycation end products on the cell 
apoptosis and senescence 
On FITC-Annexin/PI double staining, normal live cells 
were FITC-negative and PI-positive, early apoptotic cells 
were FITC-positive and PI-negative, and necrotic cells 
were FITC-positive and PI-positive. Flow cytometric 
analysis revealed that apoptosis had been induced in cells 
exposed to 10 mg/ml G-BSA for 5 days (p < 0.05) (Fig. 9). 
The apoptotic cell population was 7.57 ± 0.5% in the con-
trol group (without AGE treatment). In the experimental 
group, there was a dose-dependent increase in the apop-
totic cell population in the following order: 50 µg/mL (11.39 
± 2.4%), 100 µg/mL (16.61 ± 1.0%), and 200 µg/mL (26.91 
± 2.0%).
SA-β-gal staining was performed to investigate the ef-
fect of G-BSA on cell senescence. Senescent cells stained 
blue and began to appear after exposure to 10 µg/mL G-
BSA (Fig. 10). As the concentration of G-BSA increased, 
senescent cells were observed more frequently (Fig. 11). 
When cells were co-exposed to L-arginine, sepiapterin and 
NAC with 50 µg/mL and 100 µg/mL G-BSA, the number 
of senescent cells significantly decreased compared to the 
cells exposed to G-BSA only (Fig. 12). Thus, it appears that 
AGE induces apoptosis and promotes the senescence of 
trabecular meshwork cells.
Discussion
This study shows that AGE not only decreases cell 
survival by inducing apoptosis, but also promotes the se-
nescence of trabecular meshwork cells accompanied by 
increased oxidative stress. AGE is a composite substance 
formed by non-enzymatic glycation that changes the struc-
ture and the function of proteins. The permanent glyca-
tion of protein is closely linked to oxidative stress. AGE is 
known to increase the generation of reactive free radicals 
by a process similar to lipid peroxidation, generate oxida-
tive stress in cells by activating AGE membrane receptors, 
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Fig. 9. Effect of advanced glycation end products (AGE) on the 
induction trabecular meshwork cell apoptosis assessed using flow 
cytometry and Annexin V/propidium iodide staining. AGE in-
creased cellular apoptosis in a dose-dependent manner compared 
to non-exposed controls (
*p < 0.05).
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Fig. 8. The advanced glycation end products (AGE)-induced in-
crease in the generation of reactive oxygen species was abolished 
by antioxidant N-acetylcysteine (NAC), but not by L-arginine or 
sepiapterin, compared to non-exposed trabecular meshwork cells 
(
*,**p < 0.05).
Fig. 10. Senescence-associated b-galactosidase staining of tra-
becular meshwork cells after exposure to advanced glycation 
end products (AGE). AGE (100 µg/mL) increased the number of 
senescent cells, which stained blue, (B) compared to non-exposed 
controls (A). Magnification, ×100.
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and induce aging, glycosuria, vascular disease and nervous 
atrophy by promoting the inflammatory response [37,38]. 
AGE is also related to various ocular diseases including 
diabetic retinopathy [39-43] and it is known to accumulate 
in the optic nerve head [44].
Dysfunction of the trabecular meshwork increases the 
resistance of the outflow pathway and induces an increase 
in intraocular pressure. It is important to maintain the nor-
mal physiological function of the trabecular meshwork be-
cause it functions in regulating outflow [20]. The number 
of trabecular meshwork cells decreases with aging [45] and 
the histopathologic findings of primary open-angle glau-
coma tissue are similar to those of aged cells [46-49].
Although NO acts as an important physiological adjust-
ing factor in the human body at low concentrations, it is 
converted into reactive oxygen species and may induce 
pathologic damage at either excess or deficient states [3-
5]. The decreased efficiency of NO in the trabecular 
meshwork not only decreases outflow as the trabecular 
meshwork shrinks, but can also cause various pathologic 
consequences as a result of decreasing physiological acti-
vation. When the physiological activation of NO decreases, 
the generation of harmful reactive oxygen species such as 
superoxide or peroxynitrite increases [50]. These reactive 
oxygen species not only induce oxidative stress but also 
bring about the senescence of cells [51-56]. In addition, 
ascorbic acid, which exists in high concentrations within 
the aqueous humor, plays a role as an antioxidant by de-
creasing oxidative stress and, thereby decreasing cellular 
senescence [57]. 
In this study, G-BSA was used as an AGE because 
glycolaldehyde has previously been reported as the best 
modifier for fast and reproducible generation of a high-
affinity receptor for AGE binding and AGE [25]. Our 
results show that AGE decreased the production of NO 
in trabecular meshwork cells. Thus, trabecular outflow 
may be decreased by contraction or inhibition of the re-
laxation of the trabecular meshwork. AGE also increased 
the generation of superoxide and reactive oxygen species. 
Superoxide could possibly be further increased by the un-
coupling of NO, and promoting the generation of harmful 
free radicals such as peroxynitrite may cause further dam-
age [58]. Thus, if the generation of NO is promoted at the 
physiological level or the synthesis of reactive oxygen spe-
cies is restrained, it may be helpful to keep the trabecular 
meshwork functionally intact to prevent further damage. 
As the results of this experiment demonstrate, L-arginine 
and sepiapterin, which participate in the generation of NO 
or NAC as antioxidants, not only increased the genera-
tion of NO, but also decreased the generation of reactive 
oxygen species. These results indicate that NO plays a role 
in keeping the outflow pathway open by relaxing the tra-
becular meshwork and in preserving the functionality of 
the trabecular meshwork, which is continually exposed to 
free radicals in the aqueous humor. The role of NO and the 
importance of oxidative stress as the mechanism underly-
ing glaucoma have been presented in recent studies [59,60].
Although AGE-induced generation of superoxide is sup-
pressed by either NO supplements or antioxidants, AGE-in-
duced generation of reactive oxygen species is suppressed 
by antioxidants only. AGEs accelerate the formation of 
superoxide, which generates peroxynitrite by reacting with 
NO. The availability of NO is related to superoxide, one of 
the mitochondrial reactive oxygen species. Therefore, the 
increased availability of NO by supplementation of L-argi-
nine and sepiapterin with inhibition by the uncoupling of 
eNOS could result in the reduced generation of superoxide. 
Our results are consistent with previous studies that found 
that AGE enhanced peroxynitrite formation mediated by 
NO and superoxide in retinal neurons [58,61,62]. Various 
reactive oxygen species other than superoxide are formed 
by AGE and this could lead to oxidative stress unrelated 
to NO or superoxide. Our findings indicate that this AGE-
induced oxidative stress could be reduced by antioxidants. 
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Fig. 11. Effect of advanced glycation end products (AGE) on the 
senescence of trabecular meshwork cells. AGE significantly in-
creased the percentage of senescence-associated β–galactosidase 
(SA-β-gal) (+) cells in a dose-dependent manner (
*p < 0.05).
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Fig. 12. L-arginine, sepiapterin, and N-acetylcysteine (NAC) sig-
nificantly decreased the advanced glycation end products (AGE)-
induced senescence of trabecular meshwork cells compared to 
controls exposed to 50 μg/mL (
*p < 0.05) or 100 μg/mL (
**p < 0.05) 
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Reactive oxygen species not only damage trabecular 
meshwork cells, but also induce apoptosis and promote cel-
lular aging, and NO is known to play a role in delaying cel-
lular senescence [10-12]. Trabecular meshwork cells of the 
human eye have been suggested as the proper model sys-
tem for the study of the cellular ageing phenomenon [63]. It 
was reported that the number of trabecular meshwork cells 
decreases due to tissue damage induced by oxidative stress 
[64-67] and senescence in glaucoma [68,69]. In this study, 
protein glycation appeared to induce functional changes 
in cells and AGE appeared to promote the senescence of 
trabecular meshwork cells. The exacerbation of trabecular 
meshwork cell senescence by AGE could be caused by oxi-
dative stress supported by NO generation and the restraint 
of cell senescence by antioxidants.
To conclude, AGE induced the senescence of cultured 
human trabecular meshwork cell, mediated by an increase 
in oxidative stress. Thus, maintaining NO generation at 
the physiological level or using antioxidants makes the 
trabecular meshwork competent not only by maintain-
ing the patency of the trabecular meshwork as an outflow 
pathway, but also by decreasing damage to and senescence 
of the trabecular meshwork due to oxidative stress. The 
senescence of trabecular meshwork cells due to oxidative 
stress could serve as a target for a therapeutic strategy to 
preventing damage in the management of glaucoma.
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